Holdco Nuvo Group D.g Ltd. · OTC:NUVOQ

Holdco Nuvo Group D.g — SPAC Merger (March 2024)

19 slides from Holdco Nuvo Group D.g's SPAC merger presentation, Mar 18, 2024

  1. Slide 1: Remote Fetal Monitoring Company Overview

    Vreni Loewen and Tatiana Lashina OB Solutions October 2022 R emote Fetal Monitoring Company Overview March 2024

  2. Slide 2: Cautionary Statement

    CAUTIONARY STATEMENT This presentation (“ Presentation ”) is provided for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Nuvo Group Ltd . , a limited liability company or

  3. Slide 3: Forward Looking Statements

    FORWARD LOOKING STATEMENTS Certain information set forth in the Presentation contains “forward - looking statements . ” Except for statements of historical fact, certain information contained herein constitutes forward - looking statements which include but are not limited to statements related to a

  4. Slide 4: Disclaimer: Additional Information and Where to Find It

    Disclaimer ADDITIONAL INFORMATION AND WHERE TO FIND IT In connection with the proposed Transaction, LAMF, Nuvo, and Holdco have prepared, and Holdco has filed with the SEC, the Registration Statement, which was declared effective by the SEC on March 1 , 2024 , that includes a document that serves as

  5. Slide 5: Nuvo Highlights

    • De - risked platform - 2 FDA 510 (k) clearances 1 and CE mark pending • Commercial launch in March 2023 - now onboarding customers, monitoring patients and generating early revenue • Proven reimbursement – public and private payers • Philips Master Partnership Agreement signed Aug 2023 • Continued

  6. Slide 6: INVU by Nuvo Case Study: Rural OB practice in Texas

    INVU by Nuvo Case Study Rural OB practice in Texas Three primary challenges : 6 Maintaining Standard of Care T wice weekly NST’s was extremely difficult or impossible for most patients. High no - show rates and/or patients late to appointments, backing up schedule. Clinical Staff Workload Significan

  7. Slide 7: Pregnancy Care is Broken

    Pregnancy Care is Broken Innovation in pregnancy care has lagged behind other healthcare practice areas M assive health equity issues in outcomes, access, and costs Contributing to 7 Innovation has lagged Massive health equity issues

  8. Slide 8: Key drivers creating tailwinds for Nuvo's business model

    Key drivers creating tailwinds for Nuvo’s business model *Maternity care deserts are counties where there are no hospitals providing obstetric care, no birth centers, no OB/GYN and no certified nurse midwives. Notes : 1) AJOG 2015, 2) March of Dimes 2022 , 3) AJMC 2019 4) CDC 2021 Vital Statistics R

  9. Slide 9: A paradigm shift advancing pregnancy care

    A paradigm shift advancing pregnancy care Antiquated technology in resource intensive clinical settings . Nuvo enables data - driven, actionable insights, anywhere , by everyone. Legacy Care Next Gen Care 9

  10. Slide 10: Today: scalable pregnancy care for clinicians & expectant mothers

    Today: scalable pregnancy care for clinicians & expectant mothers Unique Data Capture Signal Processing & Analysis Digital Tools & Services Collect Prescribe Compute Visualize Clinician - driven, prescription initiated Advancing the standard of care today and setting the foundation for tomorrow’s in

  11. Slide 11: Fetal Non-Stress Tests Create Opportunities Across the Healthcare Ecosystem

    Fetal Non - Stress Tests Create Opportunities Across the Healthcare Ecosystem x Convenience & Quality of Life x Care Empowerment and reduced barriers of access to care x Reduced PTO, travel time & expense, etc x Improved staff efficiency x Increased revenue potential x Competitive differentiation x

  12. Slide 12: Standard of care today and pioneering new care pathways tomorrow

    Pre - eclampsia Maternal Mood Disorder Preterm Birth Diabetes Nuvo Data Cloud Maternal & Fetal ECG Maternal & Fetal PCG Standard of care today and pioneering new Care Pathways tomorrow Maternal & Fetal Heart Rate Maternal Uterine Activity (MUA) Transformational Care: AI and Predictive Analytics Adva

  13. Slide 13: Value Creation Driven by Innovation & Distribution

    Value Creation Driven by Innovation & Distribution Standard of Care : Remote Fetal Surveillance Upside via Innovation $ Current Offering $$$ $$ Clinical Decision Support Systems Transformational Care : Screening & Predictive Analytics Market Access Partners Anticipated International Markets Upside v

  14. Slide 14: Reimbursement & Public Policy Accelerators In Remote Pregnancy Monitoring

    Reimbursement & Public Policy Accelerators In Remote Pregnancy Monitoring Public policy is funding improvements that address care equity Existing codes being utilized to reimburse remote NST’s by both public and private payers Remote NSTs reimbursed & endorsed Important Notice Regarding At - Home Fe

  15. Slide 15: Access to Care and Data Insights comparison

    Only in - clinic, with medical assistance Access to Care At home & in - clinic Data Insights High - resolution, rich data sets We believe Nuvo is the only company that increases access to care and generates deeper data insights Archaic modalities 15

  16. Slide 16: Patent Stats by Family

    Patent Stats by Family ▪ Issued utility patents: ─ 14 U.S. / 36 Outside U.S. ▪ Pending utility patent applications: ─ 9 U.S. / 16 Outside U.S. ▪ Allowed utility patent applications: - 1 U.S. / 2 Outside U.S. ▪ Issued design patents: ─ 3 U.S. / 7 Outside U.S. One PCT patent application Nuvo’s IP Acts

  17. Slide 17: Nuvo Public Company Leadership

    Laurence Klein Founding Investor / Private Equity Fund Owner/Manager Board of Directors Christina Spade Former CEO of AMC Gerald Ostrov Board Chairman Former Chairman & CEO of Bausch + Lomb, Former Group Chairman J&J Nuvo Public Company Leadership Douglas Blankenship Chief Financial Officer Rice Pow

  18. Slide 18: Investment Summary

    Large & growing market in need of innovation We believe Nuvo is one of the leading disruptors of status quo with 2 FDA 510(k) clearances 1 Go - to - market de - risked with commercial partnerships & reimbursed by certain existing codes Notes : 1) I NVU is cleared by the FDA for fetal heart rate, mat

  19. Slide 19: The future of pregnancy care is in our hands

    The future of pregnancy care is in our hands. Join the movement at nuvocares.com 2 4

Holdco Nuvo Group D.G — SPAC Merger (March 2024) on 6ix